Transaction in Own Shares
* Reuters is not responsible for the content in this press release.
BAGSVAERD, DENMARK, Mar 30 (MARKET WIRE) --
Novo Nordisk A/S - Share repurchase programme
On 29 January 2009 Novo
Nordisk initiated its share repurchase programme in accordance with the
provisions of the European Commission's regulation no 2273/2003 of 22
December 2003, also referred to as the Safe Harbour rules.
Under the programme Novo Nordisk will repurchase B shares for an amount
up to DKK 3.0 billion in the period from 29 January 2009 to 5 August 2009.
Since the announcement as of 23 March 2009, the following transactions
have been made under the programme:
Number of Average Transaction
shares purchase price value, DKK Accumulated, last announcement 2,892,500
831,417,245 23 March 2009 75,000 252.25 18,918,750 24 March 2009 75,000
257.45 19,308,750 25 March 2009 75,000 266.21 19,965,750 26 March 2009
75,000 275.80 20,685,000 27 March 2009 125,000 276.97 34,621,250
Accumulated under the programme 3,317,500 944,916,745
With the
transactions stated above, Novo Nordisk owns a total of 28,170,052
treasury shares, corresponding to 4.4% of the share capital. The total
amount of shares in the company is 634,000,000 including treasury shares.
Novo Nordisk is a healthcare company and a world leader in diabetes care.
In addition, Novo Nordisk has a leading position within areas such as
haemostasis management, growth hormone therapy and hormone replacement
therapy. Novo Nordisk manufactures and markets pharmaceutical products
and services that make a significant difference to patients, the medical
profession and society. With headquarters in Denmark, Novo Nordisk
employs more than 27,000 employees in 81 countries, and markets its
products in 179 countries. Novo Nordisk's B shares are listed on the
stock exchanges in Copenhagen and London. Its ADRs are listed on the New
York Stock Exchange under the symbol 'NVO'. For more information, visit
novonordisk.com.
Company Announcement no 17 / 2009
This announcement was originally
distributed by Hugin. The issuer is solely responsible for the content of
this announcement.
Copyright Copyright Hugin AS 2009. All rights
reserved.
Further information:
Media: Investors:
Outside North America: Outside North America:
Elin K Hansen Mads Veggerby Lausten
Tel: (+45) 4442 3450 Tel: (+45) 4443 7919
Email Contact Email Contact
Kasper Roseeuw Poulsen
Tel: 4442 4471
Email Contact
In North America: In North America:
Sean Clements Hans Rommer
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937
Email Contact Email Contact
Copyright 2009, Market Wire, All rights reserved.
-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters